Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.52, $0.02 better than the analyst estimate of $1.50. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.9 billion.

• Outlook for full year 2018 remains unchanged

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.